Serum thymic factor, FTS, attenuates cisplatin nephrotoxicity by suppressing cisplatin-induced ERK activation

Biochemical Pharmacology

Volumn 70, Issue 9, 2005, Pages 1408-1416

  Kohda, Yuka ^a   Kawai, Yoshiko ^a   Iwamoto, Noriaki ^a   Matsunaga, Yoshiko ^a   Aiga, Hiromi ^a   Awaya, Akira ^b   Gemba, Munekazu ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

cis Diamminedichloroplatinum II (cisplatin); ERK activation; HSP70; Nephrotoxicity; Serum thymic factor (FTS)

Indexed keywords

CISPLATIN; HEAT SHOCK PROTEIN 70; MITOGEN ACTIVATED PROTEIN KINASE; PLATINUM; THYMULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CELL STRAIN; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; IN VITRO STUDY; IN VIVO STUDY; INJECTION; KIDNEY; KIDNEY CORTEX; KIDNEY DISEASE; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION;

ANIMALS; CELL LINE; CELL NUCLEUS; CISPLATIN; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HSP70 HEAT-SHOCK PROTEINS; KIDNEY; PHOSPHORYLATION; RATS; SWINE; THYMIC FACTOR, CIRCULATING;

EID: 25644451873     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2005.08.002     Document Type: Article

References (75)

1. L.H. Einhorn Curing metastatic testicular cancer Proc Natl Acad Sci USA 99 2002 4592 4595
2. R.F. Borch The platinum antitumor drugs G. Powis RA. Prough Metabolism and action of drugs vol. 163 1987 Taylor&Francis London 193
3. B. Rosenberg Platinum complex for the treat of cancer Interdisciplinary Sci Rev 3 1978 134 147
4. A.J. Lippman, C. Helson, L. Helson, and I.H. Krakoff Clinical trials of cis-diammine-dichloro platinum (NSC-119875) Cancer Chemother Rep 57 1973 191 200
5. Y.K. Kim, H.S. Byun, Y.H. Kim, J.S. Woo, and S.H. Lee Effect of cisplatin on renal function in rabbits: mechanism of reduced glucose reabsorption Toxicol Appl Pharmacol 130 1995 19 26
6. G. Daugaard Cisplatin nephrotoxicity: experimental and clinical studies Dan Med Bull 37 1990 1 12
7. F. Ries, and J. Klastersky Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity Am J Kidney Dis 8 1986 368 379
8. N.E. Madias, and J.T. Harrington Platinum nephrotoxicity Am J Med 65 1978 307 314
9. B.J. Leonard, E. Eccleston, D. Jones, P. Todd, and A. Walpole Antileukemic and nephrotoxic properties of platinum compounds Nature 234 1971 243
10. J.S. Berns, and P.A. Ford Renal toxicities of antineoplastic drugs and bone marrow transplantation Semin Nephrol 17 1997 54 66
11. S. Chopra, J.S. Kaufman, and T.W. Jones cis-Diammine-dichloro platimum-induced acute renal failure in the rat Kidney Int 21 1982 54 64
12. I. Arany, and R.L. Safirstein Cisplatin nephrotoxicity Semin Nephrol 23 2003 460 464
13. D.C. Dobyan, J. Levi, C. Jacobs, J. Kosec, and M.W. Weiner Mecahnism of cis-platinum nephrotoxicity. II. Morphological observations J Pharmacol Exp Ther 213 1980 551 556
14. M. Gemba, T. Yamaguchi, K. Kambara, A. Suzuki, and Y. Kawai Increases in urinary enzyme excretion in rats depleted of glutathione inhibited by scavenger of oxygen free radicals Pharmacobiodynamics 15 9 1992 513 518
15. Y. Kameyama, and M. Gemba The iron chelator deferoxamine prevents cisplatin-induced lipid peroxidation in rat kidney cortical slices Jpn J Pharmacol 57 2 1991 259 262
16. G.J. Schaaf, R.F. Maas, and E.M. Groene Management of oxidative stress by heme oxygenase-1 in cisplatin-induced toxicity in renal tubular cells Free Radic Res 36 2002 835 843
17. T. Xiao, S. Choudhary, and W. Zhang Possible involvement of oxidative stress in cisplatin-induced apoptosis in LLC-PK1 cells J Toxicol Environ Health 66 2003 469 479
18. N.P. Vermeulen, and G.S. Baldew The role of lipid peroxidation in the nephrotoxicity of cisplatin Biochem Pharmacol 44 6 1992 1193 1199
19. J.G. Zhang, and W.E. Lindup Role of mitochondria in cisplatin-induced oxidative damage exhibited by rat renal cortical slices Biochem Pharmacol 45 11 1993 2215 2222
20. J. Deng, Y. Kohda, and H. Chiao Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury Kidney Int 60 2001 2118 2128
21. G. Ramesh, and W.B. Reeves TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity J Clin Invest 110 2002 835 842
22. B.S. Cummings, and R.G. Schnellmann Cisplatin-induced renal cell apoptosis: caspase 3-dependent and -independent pathway J Pharmacol Exp Ther 302 2002 8 17
23. 1: implication of the functions of apical membranes Biochem Pharmacol 59 2000 195 201
24. A.H. Lau Apoptosis induced by cisplatin nephrotoxic injury Kidney Int 56 1999 1295 1298
25. W. Lieberthal, V. Triaca, and J. Levine Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: apoptosis vs. necrosis Am J Physiol 270 1996 F700 F708
26. B. Desoize, and C. Madoulet Particular aspects of platinum compounds used at present in cancer treatment Crit Rev Oncol Hematol 42 2002 317 325
27. M.W. English, R. Skinner, A.D.J. Pearson, L. Price, R. Wyllie, and A.W. Craft Dose-related nephrotoxicity of carboplatin in children Br J Cancer 81 1999 336 341
28. M.C. Poirier, E. Reed, C.L. Litterst, D. Kats, and S. Gupta-Burt Persistence of platinum-ammine-DNA adducts in gonads and kidneys of rats and multiple tissues from cancer patients Cancer Res 52 1992 149 153
29. D.S. Alberts, P.T. Fanta, K.L. Running, L.P. Adair, D.J. Garcia, and R. Liu-Stevens In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human ovarian cancers Cancer Chemother Pharmacol 39 1997 493 497
30. N. Uchida, Y. Takeda, K. Hojo, R. Maekawa, K. Sugita, and T. Yoshioka Sequence-dependent antitumour efficacy of combination chemotherapy of nedaplatin, a novel platinum complex, with 5-fluorouracil in an in vivo murine tumour model Eur J Cancer 34 1998 1796 1801
31. Y. Kawai, S. Taniuchi, S. Okahara, M. Nakamura, and M. Gemba Relationship between cisplatin or nedaplatin-induced nephrotoxicity and renal accumulation Biol Pharm Bull 28 8 2005 1385 1388
32. J.F. Bach, M. Dardenne, and J.M. Pleau Biological characterization of a serum thymic factor Nature 266 1977 55 56
33. D.B. Kaufman Maturational effects of thymic hormones on human helper and suppressor T cells: effect of FTS ('Factuer Thymique Serique') and thymosin Clin Exp Immunol 39 1980 722 727
34. J.F. Bach Thymulin (FTS-Zn) Clin Immunol Allergy 3 1983 133 156
35. M.A. Bach, and G. Beaurain Respective influence of extrinsic and intrinsic factors on age-related decrease of thymic secretion J Immunol 122 1979 1056 1058
36. J.F. Bach, M. Dardenne, J.M. Pleau, and M.A. Bach Isolation biochemical characteristic and biological activity of circulating thymic hormone in the mouse and in the human Ann N Y Acad Sci 249 1975 186 193
37. M. Dardenne, B. Nabama, P. Lefancier, M. Denien, J. Choay, and J.F. Bach Contribution of zinc and other metals to the biological activity of the serum thymic factor Proc Natl Acad Sci USA 79 1982 5370 5373
38. W. Savino, and M. Dardenne Neuroendocrine control of thymus physiology Endocr Rev 21 2000 412 443
39. M. Mizutani, M. EI-Fotoh, M. Mori, K. Ono, K. Doi, and A. Awaya In vivo administration of serum thymic factor (FTS) prevents EMC-D virus-induced diabetes and myocarditis in BALB/cAJ cl mice Arch Virol 141 1996 73 83
40. T. Yamanouchi, H. Moromizato, S. Kojima, T. Shinohara, N. Sekino, and S. Minoda Prevention of diabetes by thymic hormone in alloxan-treated rats Eur J Pharmacol 257 1994 39 46
41. Y. Nagai, T. Osanai, and K. Sakakibara Intensive suppression of experimental allergic encephalomyelitis (EAE) by serum thymic factor and therapeutic implication for multiple sclerosis Jpn J Exp Med. 52 4 1982 213 219
42. A. Barbul, T. Shawe, H.L. Frankel, J.E. Efron, and H.L. Wasserkrug Inhibition of wound repair by thymic hormones Surgery 106 1989 373 377
43. W. Welch, H.S. Kang, and L.A. Mizzen Response of mammalian cells to metabolic stress: changes in cell physiology and structure/function of stress proteins Curr Top Microbiol Immunol 137 1994 31 35
44. T. Langer, and W. Neupert Heat shock proteins hsp60 and hsp70: their roles in folding, assembly and membrane translocation of proteins Curr Top Microbiol Immunol 167 1991 3 29
45. D. Ang, K. Liberek, and D. Skowtra Biological role and regulation of the universally conserved heat shock proteins J Biol Chem 266 36 1991 24233 24236
46. D. Andrés, M. Bautista, and M. Cascales Attenuation of cyclosporine A toxicity by sublethal heat shock: role of catalase Biochem Pharmacol 69 3 2005 493 501
47. A. Komatsuda, H. Wakui, and H. Imai Renal localization of the constitutive 73-kDa heat-shock protein in normal and PAN rats Kidney Int 41 1992 1204 1212
48. A. Komatsuda, H. Wakui, Y. Oyama, H. Imai, and A. Miura Overexpression of the human 72 kDa heat shock protein in renal tubular cells confers resistance against oxidative injury and cisplatin toxicity Nephrol Dial Transport 14 1999 1385 1390
49. M.H. Cobb, and E.J. Goldsmith How MAP kinase are regulated J Biol Chem 270 1995 14843 14846
50. T.S. Lewis, P.S. Shapiro, and N.G. Ahn Signal transduction through MAP kinase cascades Adv Cancer Res 74 1998 49 139
51. + transport, and cisplatin-induced apoptosis in renal cells J Biol Chem 277 2002 43377 43388
52. D.L. Persons, E.M. Yazlovitskaya, W. Cui, and J.C. Pelling Cisplatin-induced activation of mitogen-activated protein kinases in ovarian carcinoma cells: inhibition of extracellular signal-regurated kinase activity increases sensitivity to cisplatin Clin Cancer Res 5 1999 1007 1014
53. I. Sanches-Perea, J.R. Murguia, and R. Perona Cisplatin induces a persistent activation of JNK that is related to cell death Oncogene 16 1998 533 540
54. X. Wang, J.L. Martindale, and N.J. Holbrook Repuirement for ERK activation in cisplatin-induced apoptosis J Biol Chem 275 2000 39435 39443
55. I. Arany, J.K. Megyesi, H. Kaneto, P.M. Price, and R.L. Safirstein Cisplatin-induced cell death is EGFR/src/ERK signaling dependent in mouse proximal tubule cells Am J Physiol Renal Physiol 287 2004 F543 F549
56. T.G. Boulton, S.H. Nye, D.J. Robbins, N.Y. Ip, E. Radziejewska, and S.D. Morgenbesser ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF Cell 65 1991 663 675
57. R.J. Davis The mitogen-activated protein kinase signal transduction pathway J Biol Chem 268 1993 14553 14556
58. S.K. Jo, W.Y. Cho, S.A. Sung, H.K. Kim, and N.H. Won MEK inhibitor, U0126, attenuates cisplatin-induced renal cell injury by decreasing inflammation and apoptosis Kidney Int 67 2005 458 466
59. R. Campos-Gonzalez, and M.S. Kindy Tyrosine phosphorylation of microtubule-associated protein kinase after transient ischemia in the gerbil brain J Neurochem 59 1992 1955 1958
60. M.S. Kindy Inhibition of tyrosine phosphorylation prevents delayed neuronal death following cerebral ischemia J Cereb Blood Flow Metab 13 1993 372 377
61. A. Bonni, A. Brunet, A.E. West, S.R. Datta, M.A. Takasu, and M.E. Greenberg Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms Science 286 1999 1358 1362
62. M.H. Cobb MAP kinase pathways Prog Biophys Mol Biol 71 1999 479 500
63. J.D. Dignam, R.M. Lebovitz, and R.G. Roeder Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei Nucleic Acids Res 11 5 1983 1475 1489
64. S. Yara, K. Kawakami, N. Kudeken, M. Tohyama, K. Teruya, and T. Chinen FTS reduces bleomycin-induced cytokine and chemokine production and inhibits pulmonary fibrosis in mice Clin Exp Immunol 124 1 2001 77 85
65. Y. Kohda, J. Hiramatsu, and M. Gemba Involvement of MEK/ERK pathway in cephaloridine-induced injury in rat renal cortical slices Toxicol Lett 143 2003 185 194
66. Y. Matsunaga, Y. Kawai, Y. Kohda, and M. Gemba Involvement of activation of NADPH oxidase and extracellular signal-regulated kinase (ERK) in renal cell injury induced by zinc J Toxicol Sci 30 2 2005 135 144
67. S. Ishizuka, T. Yano, K. Hagiwara, M. Sone, H. Nihei, and H. Ozasa Extracellular signal-regulated kinase mediates renal regeneration in rats with myoglobinuric acute renal injury Biochem Biophys Res Commun 254 1 1999 88 92
68. S.Q. Wei, L.H. Sui, J.H. Zheng, G.M. Zhang, and Y.L. Kao Role of ERK1/2 kinase in cisplatin-induced apoptosis in human ovarian carcinoma cells Chin Med Sci J 19 2004 125 129
69. K. Aoki, T. Ogawa, Y. Ito, and S. Nakashima Cisplatin activates survival signals in UM-SCC-23 squamous cell carcinoma and these signal pathways are amplified in cisplatin-resistant squamous cell carcinoma Oncol Rep 11 2004 375 379
70. J. Villar, and S. Mendez-Alvarez Heat shock proteins and ventilator-induced lung injury Curr Opin Crit Care 9 2003 9 14
71. A. Fekete, A. Treszl, and Toth-Heyn P Association between heat shock protein 72 gene polymorphism and acute renal failure in premature neonates Pediatr Res 54 2003 452 455
72. O. Schroder, K.M. Schulte, and P. Ostermann Heat shock protein70 genotypes HSPA1B and HSPA1L influence cytokine concentrations and interfere with outcome after major injury Crit Care Med 31 2003 76 79
73. L.N. Gastinel, J.M. Pleau, G. Goldstein, and J.F. Bach Interaction of thymopoietin peptides with the specific receptor of facteur thymique serique (FTS) Thymus 5 2 1983 78 87
74. J. Deng, Y. Kohda, H. Chiao, Y. Wang, X. Hu, and S.M. Hewitt Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury Kidney Int 60 2001 2118 2128
75. G. Ramesh, and W.B. Reeves TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity J Clin Invest 110 2002 835 842